Navigation Links
New Bisphenol A Study Is of Very Limited Relevance to Human Health
Date:6/17/2009

ARLINGTON, Va., June 17 /PRNewswire-USNewswire/ -- The following statement can be attributed to Steven G. Hentges, Ph.D. of the American Chemistry Council's (ACC) Polycarbonate/BPA Global Group. Dr. Hentges' comments are in regard to a study from researchers at North Carolina State University (NCSU) and the National Institute of Environmental Health Sciences (NIEHS). The study, "Neonatal bisphenol A exposure alters rat reproductive development and ovarian morphology without impairing activation of gonadotropin releasing hormone neurons," was funded by NIEHS and published online June 17 by the journal Biology of Reproduction. The study was co-authored by Heather B. Patisaul and Heather B. Adewale of NCSU and Wendy N. Jefferson and Retha R. Newbold of NIEHS.

"The American Chemistry Council (ACC) and its member companies have long-supported research to advance scientific understanding about chemicals and promote public health. To achieve these goals with limited resources, including limited use of laboratory animals, study designs should be based on sound scientific principles and data so as to be directly relevant to human health. This new study fails to meet these basic study design principles and practices.

"It is a continuing disappointment to see that researchers -- including scientists from National Institute of Environmental Health Sciences (NIEHS) -- conduct studies that involve injection of laboratory animals with bisphenol A (BPA). This experimental technique has recently been acknowledged by the NIEHS to have very limited value for assessing human health effects since people are orally exposed to BPA, not by injection. It is well-known that BPA is efficiently metabolized and rapidly eliminated from the body after oral exposure.

"The researchers also state, incorrectly, that their study is significant because it used a dose equal to the EPA reference dose for BPA, which is a science-
'/>"/>

SOURCE American Chemistry Council
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. New Bisphenol A Study Has Limited Capability to Assess Human Health Effects
2. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
3. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
4. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
5. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
6. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
7. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
8. Study Suggests High-Dose Fish Oil May Significantly Improve Behavior in Children with ADHD
9. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
10. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
11. MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...Nov.25/PRNewswire/--Reportlinker.comannouncesthata...,, MammographyEquipment-AGlobalMarketPerspect...Mammography-Equipment---A-Global-Market-Perspectiv...trializedaswellasdevelopingnationsisaprincipalfact...,escalatingawarenessaboutbreastcancerhasallowedwom...
(Date:11/25/2009)...LL,N.C.,Nov.25/PRNewswire/--CempraPharmaceuticalsI...tandchiefexecutiveofficer,willpresentatthePiperJaf...cember1,2009,atTheNewYorkPalaceHotelinNewYorkCity....leadingantibioticclinicalprogramsforthetreatmentof...CempraPharmaceuticals ,, Foundedin2006,CempraP...
(Date:11/25/2009)...VIEW,Calif.,Nov.25/PRNewswire/-- ChemoCentryx,Inc...Company,sPROTECT-1(theProspectiveRandomizedOralThe...TM)(CCX282-B)inpatientswithmoderate-to-severeCrohn...esafetyandtolerabilityprofile.Thestudydemonstrated...everityasdefinedasa70-pointdecreaseintheCrohn,sDis...
Breaking Medicine Technology:Reportlinker Adds Mammography Equipment - A Global Market Perspective 2Reportlinker Adds Mammography Equipment - A Global Market Perspective 3Reportlinker Adds Mammography Equipment - A Global Market Perspective 4Reportlinker Adds Mammography Equipment - A Global Market Perspective 5Reportlinker Adds Mammography Equipment - A Global Market Perspective 6Reportlinker Adds Mammography Equipment - A Global Market Perspective 7ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5Waterproof Cleanable Computer Keyboard Video Comparison Now Available on You Tube 61885 1Waterproof Cleanable Computer Keyboard Video Comparison Now Available on You Tube 61885 2Democratic National Committee Chairman Tim Kaines Statement on the Senates Vote to Proceed to Full Floor Debate of Health Insurance Reform Legislation 61882 1Democratic National Committee Chairman Tim Kaines Statement on the Senates Vote to Proceed to Full Floor Debate of Health Insurance Reform Legislation 61882 2River Blindness 28Onchocerciasis 29 Reduced By Nearly One Third In At Risk Populations In Six Countries 61879 1River Blindness 28Onchocerciasis 29 Reduced By Nearly One Third In At Risk Populations In Six Countries 61879 2River Blindness 28Onchocerciasis 29 Reduced By Nearly One Third In At Risk Populations In Six Countries 61879 3River Blindness 28Onchocerciasis 29 Reduced By Nearly One Third In At Risk Populations In Six Countries 61879 4
(Date:11/25/2009)... TORONTOandCALGARY,Nov.25/PRNewswire/-SentinelleMe...maging(MRI)coilsandsoftwareandCalgaryScientificInc...aveintroducedawebversionofAegis(TM)Breast4DAdvance...aceisthefirsttrulyzero-footprintWebclientbasedmedi...ureWeb(TM)platformallowsforzero-footprintaccess-re...
(Date:11/25/2009)... SANFRANCISCO,Nov.25/PRNewswire/--TheBayAreaAirQua...nter Spare the Air Alert forThursday...irelogsoranyothersolidfuel,bothindoorsandoutdoors....airqualitytomorrow,"saidJackBroadbent,executiveoff...orespectthehealthoftheirneighborsandfellowcommunit...
(Date:11/25/2009)...stress increase blood pressure? This simple quest...y years. New Stress-related gene Modulates High B... blood pressure? This simple question has been th...ew research has for the first time established a l... pressure response to stress in mice as well as hu...
(Date:11/25/2009)...rs often plagued by neurological symptoms, study f...News) -- Neurological side effects are among the p...testicular cancer who were treated with cisplatin-...e study included 1,409 Norwegian men treated for u...who took part in a follow-up survey conducted from...
(Date:11/25/2009)...IDGE, Mass. -- A cancer vaccine carried into the b...plant is the first to successfully eliminate tumor...ournal Science Translational Medicine . , The n...ogists at Harvard University, uses plastic disks i...ted under the skin to reprogram the mammalian immu...
Breaking Medicine News(10 mins):Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 3Health News:Winter Spare the Air Alert in Effect for Thursday, November 26, 2009 2Health News:New stress-related gene modulates high blood pressure in mice and men 2Health News:Implant-based cancer vaccine is first to eliminate tumors in mice 2
...ivor, Available to Speak on Root Reasons Behind ...ALTIMORE, Oct. 23 , WHAT: Hanala Stadner, L.A. a...counselor specializing in celebrities, will share ...red celebrity addict herself, Stadner is available...
...re communities throughout ...the World of,Health IT Conference and Exhibition t... Information and Management Systems Society (HIMSS... and,Africa (EMEA). (Logo: http://www.newscom.co...
... Access: freely available for anyone to read, down...he authorship is properly attributed. , This week...rticles that aim to highlight the profound influen...itors.org/globalthemeissue.cfm ): , Which inter...
...ningly real Mutter Museum gears up for Hal...HIA, Oct. 22 The skulls in the glass case may,be ...formed body parts. The,background noise is filled ...ween? This year, the Mutter Museum is taking Hall...
...ee Chairman Howard Dean issued the following state...s a request for an additional $46 billion,in war s...oed a bill to,give health care coverage to 10 mill... health care coverage to millions,of low income ch...
... this weeks issue of the Proceedings of the Nation...d against the damaging effects of ultraviolet (UV)... in our environment by topical application of an ...erythema) caused by UV rays, which is an accurate ...
Other Medicine News:Health News:L.A. Author, TV Personality and Substance Abuse Specialist Discusses Struggle to Break 'Bad-girl' Syndrome Oct. 26-28 in Baltimore 2Health News:Microsoft and HIMSS Expanding Healthcare User Group Across EMEA 2Health News:Microsoft and HIMSS Expanding Healthcare User Group Across EMEA 3Health News:Microsoft and HIMSS Expanding Healthcare User Group Across EMEA 4Health News:Which intervention would do the most to improve the health of the extreme poor? 2Health News:Which intervention would do the most to improve the health of the extreme poor? 3Health News:Which intervention would do the most to improve the health of the extreme poor? 4Health News:Which intervention would do the most to improve the health of the extreme poor? 5Health News:Halloween at The Mutter Museum 2Health News:Broccoli sprout-derived extract protects against ultraviolet radiation 2
... the world's first directly illuminated, hand-held... bringing superior ophthalmic technology to eye ca...radition, Welch Allyn now introduces the prestigio...y designed precision optics, the Coaxial-plus Opht...
...700PC/3700CF patternless processing system assures...ly and with the convenience of complete automatic ...rame Reader, advanced processing unit and large LC...onate feature (ALE-3700 PC) or a polishing feature...
Topcon FR-2 Frame Reader
...l II, is very simple to use and, furthermore, high...ause it is only necessary to coincide the split ha...hen indicating the pupillary distance, as well as ...ween the centers of spectacle lenses and the visua...
Medicine Products: